HLA-A and posterior cortical atrophy: Concerning the above, in the current study, we extended our investigation in PCa patients, irrespective of their disease status at diagnosis (i.e., LPCa or MPCa), to prospectively define the prognostic relevance of HLA-A*02:01 and HLA-A*24:02 to disease-related OS prediction as the ultimate prognostic endpoint at diagnosis, thus minimizing over-diagnosis.